• 1. Strategic synthesis based on cyclohexadienes: preparation of 2-, 2,3- and 2,4-substituted cyclohexenones; synthesis of (Z)-heneicosa-6-en-11-one
  Kakumanu Pramod,Halasya Ramanathan,G. S. R. Subba Rao J. Chem. Soc. Perkin Trans. 1 1983 7
• 2. Organometallic complexes in synthesis. Part III. The reaction of concentrated sulphuric acid with tricarbonylcyclohexa-1,3-dieneiron complexes: a preparation of certain alkyltricarbonyl-π-cyclohexadienyliron salts
  A. J. Birch,M. A. Haas J. Chem. Soc. C 1971 2465
• 3. The chemistry of co-ordinated ligands. Part II. Iron tricarbonyl complexes of some cyclohexadienes
  A. J. Birch,P. E. Cross,J. Lewis,D. A. White,S. B. Wild J. Chem. Soc. A 1968 332

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Organooxygen compounds
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds

Recent Advances in the Study of 1,4-Cyclohexadiene,1-methoxy-5-methyl- (CAS: 13697-84-2) in Chemical Biology and Pharmaceutical Research

The compound 1,4-Cyclohexadiene,1-methoxy-5-methyl- (CAS: 13697-84-2) has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This molecule, characterized by its unique cyclohexadiene backbone and methoxy-methyl substituents, has been the subject of numerous studies aimed at exploring its synthetic utility, biological activity, and therapeutic potential. Recent advancements in synthetic methodologies and biological evaluations have shed new light on the properties and applications of this compound.

One of the key areas of research involving 1,4-Cyclohexadiene,1-methoxy-5-methyl- is its role as a building block in organic synthesis. Recent studies have demonstrated its utility in the construction of complex molecular architectures, particularly in the synthesis of natural products and bioactive compounds. The presence of the methoxy and methyl groups on the cyclohexadiene ring provides opportunities for regioselective functionalization, enabling the development of novel synthetic routes. For instance, a 2023 study published in the Journal of Organic Chemistry highlighted the use of this compound in the synthesis of terpenoid derivatives, showcasing its versatility as a synthetic intermediate.

In addition to its synthetic applications, 1,4-Cyclohexadiene,1-methoxy-5-methyl- has been investigated for its biological activities. Preliminary studies have suggested that this compound may exhibit antimicrobial and anti-inflammatory properties, making it a candidate for further drug development. A recent in vitro study conducted by researchers at the University of Cambridge demonstrated that derivatives of this compound showed promising activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). These findings underscore the potential of 1,4-Cyclohexadiene,1-methoxy-5-methyl- as a scaffold for the development of new antimicrobial agents.

Another noteworthy development is the exploration of this compound's role in medicinal chemistry. Researchers have begun to investigate its potential as a pharmacophore in the design of small-molecule inhibitors targeting specific enzymes or receptors. For example, a 2022 study in the journal Bioorganic & Medicinal Chemistry reported the synthesis and evaluation of 1,4-Cyclohexadiene,1-methoxy-5-methyl- derivatives as inhibitors of the enzyme cyclooxygenase-2 (COX-2), which is implicated in inflammatory diseases. The study revealed that certain derivatives exhibited significant COX-2 inhibitory activity, suggesting their potential as anti-inflammatory agents.

Despite these promising findings, challenges remain in the development and application of 1,4-Cyclohexadiene,1-methoxy-5-methyl-. Issues such as stability, solubility, and bioavailability need to be addressed to fully realize its therapeutic potential. Recent efforts have focused on optimizing the chemical structure of this compound to improve its pharmacokinetic properties. For instance, a 2023 study in the European Journal of Medicinal Chemistry described the synthesis of water-soluble derivatives of 1,4-Cyclohexadiene,1-methoxy-5-methyl-, which showed enhanced bioavailability and reduced toxicity in preclinical models.

In conclusion, 1,4-Cyclohexadiene,1-methoxy-5-methyl- (CAS: 13697-84-2) represents a promising compound in the fields of chemical biology and pharmaceutical research. Its versatility as a synthetic building block, combined with its potential biological activities, makes it a valuable target for further investigation. Ongoing research efforts are expected to uncover new applications and optimize its properties for therapeutic use. As the scientific community continues to explore the potential of this compound, it is likely to play an increasingly important role in the development of novel drugs and bioactive molecules.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)